correction "how many stocks MSLP bought back this year"...I believe Musclepharm bought back at some reasonable prices.
Musclepharm is a great company with a great future....The management is incredible hardworking and creative...but the management lacks trustworthiness in the investment community because of some badly advised actions in the past. Compensation gets all the attention when a company is under SEC investigation. First assumption by investors is that the people behind the company are greedy....even if they just want to be paid fairly for their work.
Brad did not wrap things so nicely as he should have...no, he gave the impression from the onset of this year that management gonna be rewarded generously...almost in the same sentence he mentions the ongoing SEC investigation.
Musclepharm owe the investors to get that SEC investigation concluded and implement regular compensation plans similar to other Nasdaq listed companies. There is not so much to reward until you cease being listed over the counter.
I think it's a great idea to compensate executives partially with stock and stock bonuses, and have restrictions in place for when they want to sell it. It gives them more skin in the game, it'll motivate them.
News 
Market Data 
Discover 
